Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress

• Hlavní autoři: Anabel Torrente-López (Autor), Jesús Hermosilla (Autor), Antonio Salmerón-García (Autor), José Cabeza (Autor), Natalia Navas (Autor)
• Médium: Kniha
• Vydáno: MDPI AG, 2022-03-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Nivolumab, formulated in the medicine Opdivo^® (10 mg/mL), is a therapeutic monoclonal antibody (mAb) used in the treatment of different types of cancer. Currently, there is insufficient knowledge about the behaviour of this protein with regards to the risk associated with its...